Abstract
Long-term follow-up of epidermolysis bullosa in real practice shows stability of the Epidermolysis Bullosa Disease Activity and Scarring Index and improvement with some off-label therapies
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have